Antibiotic Resistance - Managing Resistant Infections in Nursing Practice

Antibiotic resistance remains one of the most pressing challenges in modern healthcare, posing significant threats to patient safety and public health. As frontline caregivers, Registered Nurses play a critical role in preventing and managing the spread of resistant infections in various clinical settings.

This CME/CE course, 'Antibiotic Resistance – Managing Resistant Infections in Nursing Practice', offers nurses a comprehensive understanding of the biological mechanisms that drive resistance, such as enzymatic inactivation, target site alterations, reduced drug permeability, and metabolic bypass pathways. These mechanisms can severely compromise the effectiveness of once-reliable antibiotics, leaving patients vulnerable to prolonged illness, complications, and increased healthcare costs.

The course provides an in-depth look at healthcare-associated infections (HAIs), including the environmental and procedural factors that contribute to their occurrence. Participants will explore how invasive devices, immunocompromised states, and lapses in infection control can facilitate the spread of multidrug-resistant organisms (MDROs). Key pathogens discussed include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococci (VRE), and penicillin-resistant Streptococcus pneumoniae. Learners will understand their epidemiology, clinical impact, and evidence-based treatment strategies.

The course emphasizes the importance of antimicrobial stewardship—a coordinated approach to optimizing antibiotic use while minimizing resistance. Nurses will learn their role in educating patients, promoting adherence, and participating in stewardship initiatives. Diagnostic tools such as culture and sensitivity testing will be explained, enabling participants to interpret reports accurately and advocate for targeted therapy. The program integrates case-based learning and current CDC guidelines to support real-world clinical application.

By the end of this course, RNs will be equipped with the knowledge and practical skills to lead in the battle against antibiotic resistance, improving patient outcomes and safeguarding the future of antimicrobial therapy.

Educational Objectives

• Understand the antibiotic resistance mechanisms, including enzymatic inactivation, target alteration, decreased drug permeability, and metabolic pathway changes.
• Identify key strategies for preventing the emergence and spread of resistant infections, including proper antimicrobial stewardship and infection control practices.
• Recognize common healthcare-associated infections (HAIs) and the role of invasive devices, patient flora, and healthcare environments in their transmission.
• Differentiate between major resistant bacterial strains such as MRSA, VRE, and penicillin-resistant Streptococcus pneumoniae, and understand their mechanisms of resistance and treatment options.
• Apply knowledge of diagnostic techniques, including culture and sensitivity testing, to guide appropriate antibiotic selection and minimize the risk of resistance development.

Who Should Do This Course

This course is specifically designed for:

• Registered Nurses (RNs)
• Nurse Practitioners (NPs)
• Infection Control Nurses
• Medical-Surgical Nurses
• Critical Care and Community Health Nurses

Also recommended for nurses working in:

• Emergency Departments
• Geriatrics
• Pediatrics
• Oncology
• Nephrology Settings

This course is especially beneficial for those seeking to expand their knowledge in infectious disease management and antibiotic stewardship to reduce healthcare-associated infections and optimize patient outcomes in multidisciplinary care teams.

Did You Know?

• According to the CDC, more than 2.8 million antibiotic-resistant infections occur in the U.S. each year, resulting in over 35,000 deaths. (CDC, 2022)
• MRSA infections can double a patient’s length of stay and increase healthcare costs significantly. (JAMA, 2019)
• Proper hand hygiene can reduce the spread of healthcare-associated infections by up to 40%. (WHO, 2020)
• The use of broad-spectrum antibiotics without appropriate culture confirmation is a leading contributor to resistance. (Clinical Infectious Diseases, 2021)
• Antimicrobial stewardship programs have been shown to reduce inappropriate antibiotic use by 19–30%. (The Lancet Infectious Diseases, 2018)